Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
about
Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease.Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD.Recent advances in the management of chronic obstructive pulmonary disease.Factors associated with the incidence of serious adverse events in patients admitted with COPD acute exacerbation.Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
P2860
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
@ast
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
@en
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
@nl
type
label
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
@ast
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
@en
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
@nl
prefLabel
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
@ast
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
@en
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
@nl
P2093
P2860
P1476
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
@en
P2093
John White
Leanne Cheyne
Melanie J Irvin-Sellers
P2860
P356
10.1002/14651858.CD009552.PUB3
P577
2015-09-22T00:00:00Z